BioNTech SE (BNTX) September call option implied volatility flat
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) September call option implied volatility is at 44, October is at 37; compared to its 52-week range of 30 to 71 after FDA announces approval for 2023-2024 COVID-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)
- Intuitive Machines (LUNR) call put ratio 1.9 calls to 1 put as share price down 9%
- Firefly Aerospace (FLY) call put ratio 1 call to 1.3 puts as share price down 6.7%
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
